9 Meters Biopharma Inc. (NMTRQ)

9 Meters Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	29.66	46.99	37.85	4.59	5.73
Short-Term Investments	0	0	0.08	0.08	0.08
Cash & Cash Equivalents	29.66	46.99	37.93	4.67	5.8
Cash Growth	-36.89%	23.91%	712.49%	-19.57%	1532.31%
Other Current Assets	3.36	2.99	1	0.56	0.61
Total Current Assets	33.02	49.99	38.93	5.22	6.41
Property, Plant & Equipment	0.12	0.18	0.23	0.07	0.04
Other Long-Term Assets	0.01	0.01	0.01	0.01	0.01
Total Long-Term Assets	0.13	0.19	0.23	0.07	0.04
Total Assets	33.15	50.17	39.16	5.3	6.45
Accounts Payable	5.05	2.43	1.49	3.89	3.62
Current Debt	19.62	0	0.01	3.18	5.2
Other Current Liabilities	6.03	6.02	5.35	7.84	1.3
Total Current Liabilities	30.7	8.46	6.85	14.91	10.11
Long-Term Debt	0.05	0.11	0.17	0	0
Total Long-Term Liabilities	0.05	0.11	0.17	0	0
Total Liabilities	30.75	8.57	7.02	14.91	10.11
Total Debt	19.67	0.11	0.18	3.18	5.2
Debt Growth	17283.21%	-37.89%	-94.28%	-38.72%	-39.39%
Retained Earnings	-212.61	-168.84	-132.06	-70.56	-43.52
Shareholders' Equity	2.4	41.6	32.14	-9.61	-3.66
Net Cash / Debt	9.99	46.88	37.74	1.48	0.61
Net Cash / Debt Growth	-78.69%	24.20%	2444.65%	144.27%	-
Net Cash Per Share	0.77	3.86	7.15	0.89	0.49
Working Capital	2.32	41.53	32.08	-9.69	-3.7
Book Value Per Share	0.18	3.42	6.08	-5.77	-2.96

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).